Skip to main content

Site notifications

Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Merck Sharp & Dohme (Australia) Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (139)
ARTG (79)
Prescription medicine registration (62)
Australian public assessment report (AusPar) (33)
Designation or determination (31)
Prescription medicine evaluation (5)
Prescription medicine decision summary (3)

Date

2026 (5)
2025 (35)
2024 (23)
2023 (32)
2022 (29)
2021 (31)
2020 (37)
2019 (52)
2018 (23)
2017 (3)
2016 (10)
2015 (6)
2014 (9)
2013 (13)
2012 (6)
2011 (3)
2009 (10)
2008 (1)
2007 (2)
2006 (8)
2005 (1)
2003 (1)
2002 (3)
2000 (1)
1998 (1)
1997 (5)
1993 (1)
1991 (1)

Search

Sponsor content

352 result(s) found, displaying 241 to 250

KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial (263932)

8 March 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial.
NITRO-DUR 10 glyceryl trinitrate 80mg (10mg/24h) transdermal drug delivery system, sachet Cancelled under Section 30(1)(c) of the Act

4 February 2019

Cancellation by sponsor

Requested by Merck Sharp & Dohme (Australia) Pty Ltd
NITRO-DUR 15 glyceryl trinitrate 120mg (15mg/24h) Transdermal drug delivery system, sachet Cancelled under Section 30(1)(c) of the Act

4 February 2019

Cancellation by sponsor

Requested by Merck Sharp & Dohme (Australia) Pty Ltd
NITRO-DUR 5 glyceryl trinitrate 40mg (5mg/24h) transdermal drug delivery system, sachet Cancelled under Section 30(1)(c) of the Act

4 February 2019

Cancellation by sponsor

Requested by Merck Sharp & Dohme (Australia) Pty Ltd
NITRO-DUR 7.5 glyceryl trinitrate 60mg (7.5mg/24h) transdermal drug delivery system, sachet Cancelled under Section 30(1)(c) of the Act

4 February 2019

Cancellation by sponsor

Requested by Merck Sharp & Dohme (Australia) Pty Ltd
CRIXIVAN indinavir 200mg (as sulfate) capsule bottle Cancelled under Section 30(1)(c) of the Act

4 February 2019

Cancellation by sponsor

Requested by Merck Sharp & Dohme (Australia) Pty Ltd
CRIXIVAN indinavir 400mg (as sulfate) capsule bottle Cancelled under Section 30(1)(c) of the Act

4 February 2019

Cancellation by sponsor

Requested by Merck Sharp & Dohme (Australia) Pty Ltd
CUBICIN (Merck Sharp & Dohme (Australia) Pty Ltd)

22 January 2019

Prescription medicine registration

Active ingredients: daptomycin.
DELSTRIGO (Merck Sharp & Dohme (Australia) Pty Ltd)

18 January 2019

Prescription medicine registration

Active ingredients: tenofovir disoproxil fumarate; lamivudine; doravirine.
PIFELTRO (Merck Sharp & Dohme (Australia) Pty Ltd)

18 January 2019

Prescription medicine registration

Active ingredients: doravirine.

Pages

First page
Previous page
…
Page 21
Page 22
Page 23
Page 24
Current page 25
Page 26
Page 27
Page 28
Page 29
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia